SCHEMBL5598429

SCHEMBL5598429

CCc1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)ncc34)cc2)n[nH]1

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 11/20 0.65
FLT3 P36888 7/20 0.65
KDR P35968 7/20 0.65
CSF1R P07333 9/20 0.64
MET P08581 7/20 0.52
FLT4 P35916 1/20 0.51
ENPP1 P22413 1/20 0.46
ALDH1A1 P00352 1/20 0.45
MAPK10 P53779 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KIT P10721 2/20 0.44
PDGFRA P16234 2/20 0.44
RET P07949 1/20 0.44
DDR1 Q08345 1/20 0.44
KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2172536 0.89 KDR (0.81) PDGFRBFLT3KDRCSF1RMET
SCHEMBL5598197 0.85 PDGFRB (0.59) PDGFRBFLT3KDRCSF1RMET
SCHEMBL2174633 0.83 PDGFRB (0.67) PDGFRBFLT3KDRCSF1RMET
SCHEMBL4214384 0.79 PDGFRB (0.77) PDGFRBFLT3KDRCSF1RMET
SCHEMBL5598979 0.78 CSF1R (0.64) PDGFRBFLT3KDRCSF1RMET
SCHEMBL5610715 0.77 SMN1; SMN2 (0.55) PDGFRBFLT3KDRCSF1RMET
SCHEMBL5599019 0.77 PDGFRB (0.64) PDGFRBFLT3KDRCSF1RMET
SCHEMBL2173131 0.77 MET (0.64) PDGFRBFLT3KDRCSF1RMET
SCHEMBL2174860 0.76 MET (0.63) PDGFRBFLT3KDRCSF1RMET
SCHEMBL4513314 0.75 PDGFRB (0.65) PDGFRBFLT3KDRCSF1RMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007113565-A1 NAPHTHYRIDINE DERIVATIVES AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2007-10-11 WO disclosed